Targeted adenoviral vectors for cancer gene therapy (review)

International Journal of Oncology

Volumn 11, Issue 2, 1997, Pages 341-348

  Douglas, Joanne T ^a   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adenoviral vector; Cancer gene therapy; Fibre; Knob; Ligand; Penton base; Target

Indexed keywords

CAPSID PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; GENETICS; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS INFECTION;

EID: 0030787015     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.2.341     Document Type: Article

References (24)

1. Seemayer TA and Cavenee WK: Molecular mechanisms of oncogenesis. Lab Invest 60: 585-599, 1989.
2. Roth JA and Cristiano RJ: Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89: 21-39, 1997.
3. Gutierrez AA, Lemoine NR and Sikora K: Gene therapy for cancer. Lancet 339: 715-721, 1992.
4. Sikora K: Gene therapy for cancer. Trends Biotech 11: 197-201, 1993.
5. Douglas JT and Curiel DT: Targeted gene therapy. Tumor Targeting 1: 67-84, 1995.
6. Moolten FL: Drug sensitivity ('suicide') genes for selective cancer chemotherapy. In: The Internet Book of Gene Therapy. Sobol RE and Scanlon KJ (eds). Appleton & Lange, Connecticut, pp119-128, 1995.
7. Blankenstein T: Increasing tumour immunogenicity by genetic modification. Eur J Cancer 30A: 1182-1187, 1994.
8. Ross G, Erickson R, Knorr D, Motulsky AG, Parkman R, Samulski J, Straus SE and Smith BR: Gene therapy in the United States: a five-year status report. Hum Gene Ther 7: 1781-1790, 1996.
9. Chen SH, Shine HD, Goodman JC, Grossman RG and Woo SL: Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91: 3054-3057, 1994.
10. Chen L, Chen D, Manome Y, Dong Y, Fine HA and Kufe DW: Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J Clin Invest 96: 2775-2782, 1995.
11. Hwang HC, Smythe WR, Elshami AA, Kucharczuk JC, Amin KM, Williams JP, Litzky LA, Kaiser LR and Albelda SM: Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Amer J Respir Cell Molec Biol 13: 7-16, 1995.
12. Rosenfeld ME, Wang M, Siegal GP, Alvarez RD, Mikheeva G, Krasnykh V and Curiel DT: Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma. J Mol Med 74: 455-462, 1996.
13. Yee D, McGuire SE, Brunner N, Kozelsky TW, Allred DC, Chen SH and Woo SL: Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Hum Gene Ther 7: 1251-1257, 1996.
14. Brand K, Arnold W, Bartels T, Lieber A, Kay MA, Strauss M and Dorken B: Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther 4: 9-16, 1997.
15. Sterman DH, Treat J, Elshami AA, Amin K, Molnar-Kimber K, Coonrod LE, Recio A, Wilson JM, Roberts JR, Litzky LA, Albelda SM and Kaiser LR: A phase I clinical trial of adenoviral-mediated herpes simplex virus thymidine kinase gene therapy for malignant mesothelioma: preliminary results. Cancer Gene Ther 3: 529, 1996.
16. Anderson WF: Human gene therapy. Science 256: 808-813, 1992.
17. Lemarchand P, Jones M, Yamada I and Crystal RG: In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 72: 1132-1138, 1993.
18. Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, Thorgeirsson SS, Stratford-Perricaudet LD, Perricaudet M, Pavirani A, Lecocq J-P and Crystal RG: Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet 1: 372-378, 1992.
19. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, Read M, Brinkhous KM and Woo SLC: In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91: 2353-2357, 1994.
20. Liu Y, Liggitt D, Zhong W, Tu G, Gaensler K and Debs R: Cationic liposome-mediated intravenous gene delivery. J Biol Chem 270: 24864-24870, 1995.
21. Stratford-Perricaudet LD, Makeh I, Perricaudet M and Briand P: Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 90: 626-630, 1992.
22. Huard J, Lochmuller H, Acsadi G, Jani A, Massie B and Karpati G: The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 2: 107-115, 1995.
23. Philipson L, Lonberg-Holm K and Pettersson U: Virus-receptor interaction in an adenovirus system. J Virol 2: 1064-1075, 1968.
24. Wickham TJ, Mathias P, Cheresh DA and Nemerow GR: Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319, 1993.